CBIO - Catalyst Biosciences - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $14.66. This is a potential upside of $0.86 (6.23%) from yesterday's end of day stock price of $13.8.

Catalyst Biosciences's activity chart (see below) currently has 8 price targets and 9 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 66.67% with an average time for these price targets to be met of 98 days.

Most recent stock forecast was given by CHRISTOPHER RAYMOND from PIPER SANDLER on 31-Mar-2022. First documented stock forecast 04-Jan-2019.

Best performing analysts who are covering CBIO - Catalyst Biosciences:

Christopher Raymond Kevin Degeeter Timur Ivannikov

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$3

$-10.79 (-78.25%)

$4

3 years 4 months 20 days ago
(31-Mar-2022)

5/5 (100%)

$-1.24 (-29.25%)

98

Hold

3 years 9 months 4 days ago
(16-Nov-2021)

1/1 (100%)

$-14.38 (-43.08%)

196

Buy

$24

$23.52 (4900.00%)

6 years 7 months 16 days ago
(04-Jan-2019)

0/1 (0%)

$18.19 (313.08%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CBIO (Catalyst Biosciences) average time for price targets to be met?

On average it took 98 days on average for the stock forecasts to be realized with a an average price target met ratio 66.67

Which analyst has the current highest performing score on CBIO (Catalyst Biosciences) with a proven track record?

CHRISTOPHER RAYMOND

Which analyst has the current lower performing score on CBIO (Catalyst Biosciences) with a proven track record?

TIMUR IVANNIKOV

Which analyst has the most public recommendations on CBIO (Catalyst Biosciences)?

Christopher Raymond works at PIPER SANDLER and has 12 price targets and 8 ratings on CBIO

Which analyst is the currently most bullish on CBIO (Catalyst Biosciences)?

Kevin Degeeter with highest potential upside - $23.52

Which analyst is the currently most reserved on CBIO (Catalyst Biosciences)?

Christopher Raymond with lowest potential downside - -$10.79

Catalyst Biosciences in the News

Crescent Biopharma Reports Second Quarter 2025 Financial ResultsĀ and Recent Business Highlights

Completed Merger with GlycoMimetics and Previously Announced $200 Million Private Financing Supporting Pipeline of Next Generation Therapeutics for Solid Tumors Recent Leadership Appointments Bring Deep Experience in Oncology Drug Development, Clinical Operations and Building Biotechnology Companies On Track to Submit IND Application for CR-001, a PD-1 x VEGF Bispecific Antibody, in Fourth Quarter of 2025,...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?